Tacrolimus vs. cyclosporine immunosuppression: results in advanced-stage disease compared with historical controls treated exclusively with cyclosporine.

Horowitz, M M; Przepiorka, D; Bartels, P; Buell, D N; Zhang, M J; Fitzsimmons, W E; Erdman, J; Huang, C; Hodosh, E; Maher, R; Wingard, J R

Horowitz, M M; Przepiorka, D; Bartels, P; Buell, D N; Zhang, M J; Fitzsimmons, W E; Erdman, J; Huang, C; Hodosh, E; Maher, R; Wingard, J R.

Affiliation

Horowitz MM; International Bone Marrow Transplant Registry, Medical College of Wisconsin, Milwaukee, USA.

Biol Blood Marrow Transplant ; 5(3): 180-6, 1999.

Article in En | MEDLINE | ID: mdl-10392964

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tacrolimus / Cyclosporine / Immunosuppressive Agents Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Biol Blood Marrow Transplant Journal subject: HEMATOLOGIA / TRANSPLANTE Year: 1999 Document type: Article Affiliation country: Estados Unidos

Search on Google

Add to My VHL

XML

PubMed Links